Dankner tops list of best executives

Teva Pharmaceuticals Industries No. 1 company six years in a row

By SHARON WROBEL
April 15, 2010 02:46
2 minute read.
nochi dankner 224

nochi dankner 88 248. (photo credit: Courtesy)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

IDB Holding Corp. chairman Nochi Dankner has been named the country’s most respected executive by Business Data Israel Coface for the second consecutive year.

“Dankner’s successful management during the global crisis was the main reason for the high ranking in all categories,” the business information firm’s economists said in their report.

Bank Leumi president and CEO Galia Maor was ranked No. 2, up from No. 4 last year. Teva Pharmaceuticals Industries president and CEO Shlomo Yanai repeated at No 3. Industrialist Eli Hurvitz, who last month stepped down as Teva’s chairman after 25 years, dropped to No. 4 from No. 2. Strauss Group chairwoman Ofra Strauss maintained her No. 5 ranking.

Rounding out the top 10, Real-estate tycoon Yitzhak Tshuva, who was No. 1 in 2007, was No. 6, up from No. 18 last year. Mizrahi Tefahot Bank president and CEO Eli Yones was No. 7, up from No. 12. Cellcom Israel president and CEO Amos Shapira was No. 8, down from No. 6. First International Bank of Israel president and CEO Smadar Barber Tzadik was No. 9, up from No. 13. New Hamashbir Lazarchan CEO Rami Shavit was No. 10.

BDI Coface has been compiling annual rankings for six years. They are based on a sample survey of 500 leading company managers who are asked about leadership, innovation, products and services, and financial and marketing excellence, among other topics.

Eurocom Group chairman Shaul Elovitch made the biggest jump in the rankings, to No. 13 from No. 40, following his acquisition of the controlling interest in Bezeq Telecommunication Corp.
Gazit-Globe chairman Haim Katzman was No. 29, up from No. 48.


Rami Levi Chain Stores Hashikma Marketing CEO Rami Levi was No. 20, up from No. 33.

Seven women made the top 50, one fewer than last year, after Golf & Co. CEO Ilana Kaufman dropped out of the list. Three of the seven women – Maor, Strauss, and Barber Tzadik – made the top 10, followed by Intel Israel CEO Maxine Fassberg, No. 24; Bank Hapoalim controlling sharehodler Shari Arison, No. 27; Shikun & Binui chairwoman Ravit Barniv, No. 47; and Apax Partners Israel manager Zehavit Yosef, No. 50.

Teva Pharmaceuticals Industries topped BDI Coface’s list of best regarded companies for the sixth year in a row. It was followed by Partner Communications, No. 2; Strauss Group, No. 3; and Cellcom Israel, No. 4.

Bank Leumi was No. 5, up from No. 10, thanks to strong financial results in 2009, the report said. Intel Israel was No. 6, up from No. 11. Bezeq Telecommunication Corp. (No. 7) and Elbit Systems (No. 8) moved into the top 10 this year.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS